Patents by Inventor Nicholas A. Giorgio

Nicholas A. Giorgio has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20090099339
    Abstract: Chimerized and humanized versions of anti EGF receptor antibody 225 and fragments thereof for treatment of tumors.
    Type: Application
    Filed: July 9, 2008
    Publication date: April 16, 2009
    Applicant: ImClone Systems Incorporated
    Inventors: Neil I. Goldstein, Nicholas A. Giorgio, Steven Tarran Jones, Jose William Saldanha
  • Publication number: 20070116707
    Abstract: Chimerized and humanized versions of anti EGF receptor antibody 225 and fragments thereof for treatment of tumors.
    Type: Application
    Filed: June 13, 2006
    Publication date: May 24, 2007
    Inventors: Neil Goldstein, Nicholas Giorgio, Steven Jones, Jose Saldanha
  • Patent number: 7060808
    Abstract: A nucleic acid is provided which encodes a humanized antibody or fragment thereof, which encodes a protein which binds to human EGF-receptor. Monoclonal antibody 225 is the complementary determining region (CDR) donor.
    Type: Grant
    Filed: June 7, 1996
    Date of Patent: June 13, 2006
    Assignee: ImClone Systems Incorporated
    Inventors: Neil I. Goldstein, Nicholas A. Giorgio, Steven Tarran Jones, Jose William Saldanha
  • Publication number: 20040006212
    Abstract: Chimerized and humanized versions of anti EGF receptor antibody 225 and fragments thereof for treatment of tumors.
    Type: Application
    Filed: February 25, 2003
    Publication date: January 8, 2004
    Inventors: Neil I. Goldstein, Nicholas A. Giorgio, Steven Tarran Jones, Jose William Saldanha
  • Publication number: 20030224001
    Abstract: Chimerized and humanized versions of anti EGF receptor antibody 225 and fragments thereof for treatment of tumors.
    Type: Application
    Filed: February 25, 2003
    Publication date: December 4, 2003
    Inventors: Neil I. Goldstein, Nicholas A. Giorgio, Steven Tarran Jones, Jose William Saldanha
  • Patent number: 4631254
    Abstract: Process for the determination of carcinoembryonic antigen (CEA) in a sample of serum or plasma. The process comprises contacting a slightly acidic buffered sample of the serum or plasma with hydrophilic silica at room temperature, separating the silica from the sample and carrying out a radioimmunoassay for carcinoembryonic antigen on said sample.
    Type: Grant
    Filed: September 6, 1985
    Date of Patent: December 23, 1986
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Nicholas A. Giorgio, John Krupey, Leonard T. Wilson